These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33782000)

  • 41. Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients.
    Xie YL; Jin X; Yan SS; Wu CF; Xiang BX; Wang H; Liang W; Yang BC; Xiao XF; Li ZL; Pei Q; Zuo XC; Peng Y
    Front Pharmacol; 2022; 13():967412. PubMed ID: 36105229
    [No Abstract]   [Full Text] [Related]  

  • 42. Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.
    Lin YW; Zhou QT; Hu Y; Onufrak NJ; Sun S; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria.
    Choe J; Sohn YM; Jeong SH; Park HJ; Na SJ; Huh K; Suh GY; Jeon K
    Ther Adv Respir Dis; 2019; 13():1753466619885529. PubMed ID: 31680646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants: A Review of the Literature.
    Nakwan N; Chokephaibulkit K; Imberti R
    Pediatr Infect Dis J; 2019 Nov; 38(11):1107-1112. PubMed ID: 31469781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colistin in critically ill patients.
    Boisson M; Gregoire N; Couet W; Mimoz O
    Minerva Anestesiol; 2013 Feb; 79(2):200-8. PubMed ID: 23241733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis.
    Karageorgos SA; Bassiri H; Siakallis G; Miligkos M; Tsioutis C
    J Antimicrob Chemother; 2019 Sep; 74(9):2497-2506. PubMed ID: 31049586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia.
    Gkoufa A; Sou T; Karaiskos I; Routsi C; Lin YW; Psichogiou M; Zakynthinos S; Giamarellou H; Li J; Friberg LE
    Int J Antimicrob Agents; 2022 Jun; 59(6):106588. PubMed ID: 35405269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
    Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimizing colistin dosing: Is a loading dose necessary?
    Nazer LH; Anabtawi N
    Am J Health Syst Pharm; 2017 Jan; 74(1):e9-e16. PubMed ID: 28007716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic evaluation of colistin sodium.
    Michalopoulos AS; Karatza DC; Gregorakos L
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.
    Parchem NL; Bauer KA; Cook CH; Mangino JE; Jones CD; Porter K; Murphy CV
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1433-9. PubMed ID: 27230510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.
    Yapa SWS; Li J; Patel K; Wilson JW; Dooley MJ; George J; Clark D; Poole S; Williams E; Porter CJ; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2014 May; 58(5):2570-9. PubMed ID: 24550334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
    Nazer LH; Rihani S; Hawari FI; Le J
    Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
    Boisson M; Grégoire N; Cormier M; Gobin P; Marchand S; Couet W; Mimoz O
    J Antimicrob Chemother; 2017 Sep; 72(9):2607-2612. PubMed ID: 28575278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
    Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S
    J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Rigatto MH; Oliveira MS; Perdigão-Neto LV; Levin AS; Carrilho CM; Tanita MT; Tuon FF; Cardoso DE; Lopes NT; Falci DR; Zavascki AP
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2443-9. PubMed ID: 26856846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
    Jitmuang A; Nation RL; Koomanachai P; Chen G; Lee HJ; Wasuwattakul S; Sritippayawan S; Li J; Thamlikitkul V; Landersdorfer CB
    J Antimicrob Chemother; 2015; 70(6):1804-11. PubMed ID: 25698772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.
    Polat M; Kara SS; Tapısız A; Tezer H; Kalkan G; Dolgun A
    Paediatr Drugs; 2015 Aug; 17(4):323-30. PubMed ID: 25939411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.